• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物变异:理解其为何如此重要?

Biological variation: Understanding why it is so important?

作者信息

Badrick Tony

机构信息

Royal College of Pathologists of Australasia Quality Assurance Programs, St Leonards Sydney, NSW, 2065, Australia.

出版信息

Pract Lab Med. 2021 Jan 4;23:e00199. doi: 10.1016/j.plabm.2020.e00199. eCollection 2021 Jan.

DOI:10.1016/j.plabm.2020.e00199
PMID:33490349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809190/
Abstract

This Review will describe the increasing importance of the concepts of biological variation to clinical chemists. The idea of comparison to 'reference' is fundamental in measurement. For the biological measurands, that reference is the relevant patient population, a clinical decision point based on a trial or an individual patient's previous results. The idea of using biological variation to set quality goals was then realised for setting Quality Control (QC) and External Quality Assurance (EQA) limits. The current phase of BV integration into practice is using Patient-Based Real-Time Quality Control (PBRTQC) and Patient Based Quality Assurance (PBQA) to detect a change in assay performance. The challenge of personalised medicine is to determine an individual reference interval. The Athletes Biological Passport may provide the solution.

摘要

本综述将阐述生物变异概念对临床化学家日益增长的重要性。与“参考值”进行比较的理念在测量中至关重要。对于生物测量值而言,该参考值是相关患者群体、基于试验的临床决策点或个体患者的既往结果。随后,人们意识到利用生物变异来设定质量目标,以确定质量控制(QC)和外部质量保证(EQA)的限值。目前将生物变异整合到实践中的阶段是使用基于患者的实时质量控制(PBRTQC)和基于患者的质量保证(PBQA)来检测分析性能的变化。个性化医疗面临的挑战是确定个体参考区间。运动员生物护照或许能提供解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ac/7809190/d74fe25a9212/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ac/7809190/d74fe25a9212/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ac/7809190/d74fe25a9212/gr1.jpg

相似文献

1
Biological variation: Understanding why it is so important?生物变异:理解其为何如此重要?
Pract Lab Med. 2021 Jan 4;23:e00199. doi: 10.1016/j.plabm.2020.e00199. eCollection 2021 Jan.
2
Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans.医学实验室的技术质量保证和质量控制:审查并提出一个新概念,以获得综合和经过验证的 QA/QC 计划。
Crit Rev Clin Lab Sci. 2022 Dec;59(8):586-600. doi: 10.1080/10408363.2022.2088685. Epub 2022 Jun 25.
3
Impact of implementing a category 1 external quality assurance scheme for monitoring harmonization of clinical laboratories in Spain.实施1类外部质量保证计划对西班牙临床实验室监测协调的影响。
Adv Lab Med. 2020 Mar 19;1(1):20200008. doi: 10.1515/almed-2020-0008. eCollection 2020 Mar.
4
Analytical performance specifications for external quality assessment - definitions and descriptions.外部质量评估的分析性能规范——定义与描述。
Clin Chem Lab Med. 2017 Jun 27;55(7):949-955. doi: 10.1515/cclm-2017-0151.
5
Integrating Patient-Based Real-Time Quality Control (PBRTQC) in a New Field: Inter-Comparison between Biochemical Instrumentations with LDL-C.将基于患者的实时质量控制(PBRTQC)整合到一个新领域:低密度脂蛋白胆固醇(LDL-C)生化检测仪器之间的相互比较。
Diagnostics (Basel). 2024 Apr 23;14(9):872. doi: 10.3390/diagnostics14090872.
6
Spanish society of laboratory medicine external quality assurance programmes: evolution of the analytical performance of clinical laboratories over 30 years and comparison with other programmes.西班牙检验医学学会外部质量保证计划:临床实验室30年分析性能的演变及与其他计划的比较。
Adv Lab Med. 2020 May 19;1(2):20200019. doi: 10.1515/almed-2020-0019. eCollection 2020 Jun.
7
Commutability and traceability in EQA programs.EQA 计划中的互换性和可追溯性。
Clin Biochem. 2018 Jun;56:102-104. doi: 10.1016/j.clinbiochem.2018.04.018. Epub 2018 Apr 20.
8
Benefits, limitations, and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice.基于患者的实时质量控制(PBRTQC)的益处、局限性和争议以及该实践背后的证据。
Clin Chem Lab Med. 2021 Mar 10. doi: 10.1515/cclm-2021-0072.
9
A simple matrix of analytical performance to identify assays that risk patients using External Quality Assurance Program data.一种利用外部质量保证计划数据来识别对患者有风险的检测方法的简单分析性能矩阵。
Clin Biochem. 2016 May;49(7-8):596-600. doi: 10.1016/j.clinbiochem.2016.01.014. Epub 2016 Feb 1.
10
Optimization and validation of patient-based real-time quality control procedure using moving average and average of normals with multi-rules for TT3, TT4, FT3, FT3, and TSH on three analyzers.使用移动平均值和正常平均值以及多规则对 TT3、TT4、FT3、FT4 和 TSH 在三台分析仪上进行基于患者的实时质量控制程序的优化和验证。
J Clin Lab Anal. 2020 Aug;34(8):e23314. doi: 10.1002/jcla.23314. Epub 2020 May 3.

引用本文的文献

1
What's in a number: Falling on the sword of cut-off points and reference limits?数字背后的含义:倒在截断点和参考限的剑下?
J Coll Med S Afr. 2025 Jun 30;3(1):148. doi: 10.4102/jcmsa.v3i1.148. eCollection 2025.
2
Multiplexed Quantification of First-Trimester Serum Biomarkers in Healthy Pregnancy.健康妊娠早期血清生物标志物的多重定量分析
Int J Mol Sci. 2025 Aug 18;26(16):7970. doi: 10.3390/ijms26167970.
3
The individuality of plantar pressure indices enables the reduction of descriptive gait data required for diagnostic purposes.

本文引用的文献

1
Real-time, personalized medicine through wearable sensors and dynamic predictive modeling: a new paradigm for clinical medicine.通过可穿戴传感器和动态预测模型实现实时个性化医疗:临床医学的新范式。
Curr Opin Syst Biol. 2020 Apr;20:17-25. doi: 10.1016/j.coisb.2020.07.001. Epub 2020 Jul 7.
2
Patient-Based Real Time QC.基于患者的实时质量控制。
Clin Chem. 2020 Sep 1;66(9):1140-1145. doi: 10.1093/clinchem/hvaa149.
3
Implementation of patient-based real-time quality control.基于患者的实时质量控制的实施。
足底压力指数的个体性使得诊断所需的描述性步态数据得以减少。
Sci Rep. 2025 Aug 26;15(1):31438. doi: 10.1038/s41598-025-16428-0.
4
Predicting Anabolic Androgenic Steroid Doping among Specialized Health Care Patients with Elastic Net Regression Reveals Potential Laboratory Variables for "Patient Biological Passport".运用弹性网络回归预测专科医疗患者中的合成代谢雄性类固醇兴奋剂使用情况,揭示了“患者生物护照”潜在的实验室变量。
Sports Med Open. 2025 May 1;11(1):46. doi: 10.1186/s40798-025-00854-5.
5
Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells.逆转香烟烟雾诱导的慢性阻塞性肺疾病气道上皮细胞离子通道和黏液纤毛功能障碍的治疗策略。
Am J Physiol Lung Cell Mol Physiol. 2025 Apr 1;328(4):L571-L585. doi: 10.1152/ajplung.00258.2024. Epub 2025 Mar 17.
6
Biological variation of capillary blood glucose: A systematic review.毛细血管血糖的生物学变异:一项系统评价。
Biomed Rep. 2024 Oct 30;22(1):7. doi: 10.3892/br.2024.1885. eCollection 2025 Jan.
7
Using the Constrained Disorder Principle to Navigate Uncertainties in Biology and Medicine: Refining Fuzzy Algorithms.运用约束无序原理应对生物医学中的不确定性:优化模糊算法
Biology (Basel). 2024 Oct 16;13(10):830. doi: 10.3390/biology13100830.
8
Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer.一种新型集成临床化学与免疫分析分析仪的分析性能评估
Pract Lab Med. 2024 Sep 2;41:e00427. doi: 10.1016/j.plabm.2024.e00427. eCollection 2024 Aug.
9
Comparative study on the quality control effectiveness of AI-PBRTQC and traditional PBRTQC model in identifying quality risks.人工智能-PBRTQC 和传统 PBRTQC 模型在识别质量风险方面的质量控制效果比较研究。
Biochem Med (Zagreb). 2024 Jun 15;34(2):020707. doi: 10.11613/BM.2024.020707.
10
The Role and Limitations of the Reference Interval Within Clinical Chemistry and Its Reliability for Disease Detection.参考区间在临床化学中的作用和局限性及其在疾病检测中的可靠性。
Br J Biomed Sci. 2024 Feb 28;81:12339. doi: 10.3389/bjbs.2024.12339. eCollection 2024.
Crit Rev Clin Lab Sci. 2020 Dec;57(8):532-547. doi: 10.1080/10408363.2020.1765731. Epub 2020 Jun 2.
4
Harmonising EQA schemes the next frontier: challenging the status quo.协调室间质评计划:下一个前沿:挑战现状。
Clin Chem Lab Med. 2020 Oct 25;58(11):1795-1797. doi: 10.1515/cclm-2020-0343.
5
An approach to optimize delta checks in test panels - The effect of the number of rules included.一种优化测试面板中 delta 检查的方法——包含规则数量的影响。
Ann Clin Biochem. 2020 May;57(3):215-222. doi: 10.1177/0004563220904749. Epub 2020 Feb 13.
6
Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters.系统回顾和荟萃分析 20 项血液学参数的个体内和个体间生物变异估计值。
Clin Chem Lab Med. 2019 Dec 18;58(1):25-32. doi: 10.1515/cclm-2019-0658.
7
Patient-Based Real-Time Quality Control: Review and Recommendations.基于患者的实时质量控制:审查与建议。
Clin Chem. 2019 Aug;65(8):962-971. doi: 10.1373/clinchem.2019.305482. Epub 2019 Jul 1.
8
Evolution of Wearable Devices with Real-Time Disease Monitoring for Personalized Healthcare.用于个性化医疗保健的具有实时疾病监测功能的可穿戴设备的发展历程。
Nanomaterials (Basel). 2019 May 29;9(6):813. doi: 10.3390/nano9060813.
9
Bias in analytical chemistry: A review of selected procedures for incorporating uncorrected bias into the expanded uncertainty of analytical measurements and a graphical method for evaluating the concordance of reference and test procedures.分析化学中的偏差:综述了一些将未修正的偏差纳入分析测量扩展不确定度的选定程序,以及一种评估参考和测试程序一致性的图形方法。
Clin Chim Acta. 2019 Aug;495:129-138. doi: 10.1016/j.cca.2019.03.1633. Epub 2019 Mar 29.
10
Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds.设计和实施整合移动平均值和内部质量控制的质量控制计划:融合两者的最佳实践。
Clin Chem Lab Med. 2019 Aug 27;57(9):1329-1338. doi: 10.1515/cclm-2019-0027.